SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-024023
Filing Date
2016-08-11
Accepted
2016-08-11 13:18:06
Documents
66
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mcrb-10q_20160630.htm 10-Q 2023516
2 EX-10.1 mcrb-ex101_354.htm EX-10.1 174966
3 EX-31.1 mcrb-ex311_7.htm EX-31.1 9223
4 EX-31.2 mcrb-ex312_11.htm EX-31.2 9216
5 EX-32.1 mcrb-ex321_10.htm EX-32.1 7621
6 EX-32.2 mcrb-ex322_9.htm EX-32.2 7634
  Complete submission text file 0001564590-16-024023.txt   6749245

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mcrb-20160630.xml EX-101.INS 1501445
8 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20160630.xsd EX-101.SCH 41995
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20160630_cal.xml EX-101.CAL 38330
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20160630_def.xml EX-101.DEF 109167
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20160630_lab.xml EX-101.LAB 307999
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20160630_pre.xml EX-101.PRE 232890
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 161823882
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences